Isoray To Announce First Quarter Fiscal 2022 Financial Results on November 10, 2021
October 29 2021 - 8:13AM
Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and
innovator in seed brachytherapy powering expanding treatment
options throughout the body, today announced that it will host a
conference call to discuss its financial results for the first
quarter fiscal 2022 ended September 30, 2021 on Wednesday, November
10, 2021, at 4:30 p.m. Eastern Time. The Company will issue a press
release announcing its financial results for the first quarter
fiscal year 2022 after the close of the U.S. stock markets on
November 10, 2021.
To listen to the conference call, please dial (888) 506-0062.
For callers outside the U.S., please dial (973) 528-0011.
The conference call will be simultaneously webcast and can be
accessed at https://www.webcaster4.com/Webcast/Page/2199/43432. The
webcast will be available until February 10, 2022 following the
conference call.
About
IsorayIsoray, Inc. is a
medical technology company pioneering advanced treatment
applications and devices to deliver targeted internal radiation
treatments for cancers throughout the body. Isoray, Inc., through
its subsidiary, Isoray Medical, Inc., is the sole producer of
Cesium-131 brachytherapy seeds. Learn more about this innovative
Richland, Washington company and explore the many benefits and uses
of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and
Twitter.
Contact
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
IsoRay (AMEX:ISR)
Historical Stock Chart
From Mar 2024 to Apr 2024
IsoRay (AMEX:ISR)
Historical Stock Chart
From Apr 2023 to Apr 2024